PLAU and deep vein thrombosis: Finally, Pkr(IR-Ca/Pda-uPA) is decorated with cRGD peptide to obtain the final theranostic drug carrier [Pkr(IR-Ca/Pda-uPA)-cRGD], offering the targeting feature for precise drug delivery for DVT.